Heed AKS and EKRA to Properly Market Clinical Lab Services
Read this overview of legislation and regulations governing laboratory marketing practices and learn tips to ensure these activities remain compliant
Enforcement-lca
Subscribe today for access to
Articles and Reports
No Signs of the DOJ Letting Off the Pedal with Medicare Fraud Investigations
However, a new memo instructs federal prosecutors to ‘avoid overreach’ when parties cooperate with authorities
LDT Appeal: Looking at the Legal Nuances Behind Potential FDA Actions Following Court Decision
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
CMS Exercises Enforcement Discretion for PAMA Reporting
From - G2 Compliance Advisor
As we previously reported, the Centers for Medicare & Medicaid Services (CMS) has indicated that laboratories had sought relief from the March 31 deadline for reporting applicable information under the…
CMS, OIG Reps Address Attendees at ACLA Annual Meeting
From - G2 Compliance Advisor
At the American Clinical Laboratory Association annual meeting in Washington, D.C. March 23, representatives of the Centers for Medicare & Medicaid Services (CMS) and the…
Dealing with the FDA: 12 Best Practices for Responding to a Form 483
...
Already a member? Log in here
FISH Testing Case Yields $3.8 Million Settlement
From - G2 Compliance Advisor
A Florida-based urologist is the latest 21st Century Oncology defendant to fork over seven figures to settle charges of false billing for…
Fraud and Abuse Enforcement Efforts Face Declining ROI
...
Already a member? Log in here
Yates Is Gone But Her Memo Remains
...
Already a member? Log in here
Brief Your CEO about Individual Liability
From - G2 Compliance Advisor
False Claims Act (FCA) and Anti-Kickback (AKS) prosecutions against labs are just two ways the US Justice Department cracks down on…
DOJ Touts 2016 as Bumper Year for False Claim Act Recoveries
...
Already a member? Log in here